FATE THERAPEUTICS INC - 8-K Filing
Fate Therapeutics reports Q3 2026 financial results with $139.1 million in cash and an expected runway into mid-2028. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $FATE